CoChat

Ageing, Cellular Senescence and Neurodegenerative Disease

Open access
Kritsilis, Marios, V. Rizou, Sophia, Koutsoudaki, Paraskevi N., Evangelou, Konstantinos, Gorgoulis, Vassilis G., Papadopoulos, Dimitrios · 2018 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 374 of the 385 references it cites were found in a registry or an index; 63 of the 277 sources its claims cite were checked for support.

Abstract

Ageing is a major risk factor for developing many neurodegenerative diseases. Cellular senescence is a homeostatic biological process that has a key role in driving ageing. There is evidence that senescent cells accumulate in the nervous system with ageing and neurodegenerative disease and may predispose a person to the appearance of a neurodegenerative condition or may aggravate its course. Research into senescence has long been hindered by its variable and cell-type specific features and the lack of a universal marker to unequivocally detect senescent cells. Recent advances in senescence markers and genetically modified animal models have boosted our knowledge on the role of cellular senescence in ageing and age-related disease. The aim now is to fully elucidate its role in neurodegeneration in order to efficiently and safely exploit cellular senescence as a therapeutic target. Here, we review evidence of cellular senescence in neurons and glial cells and we discuss its putative role in Alzheimer’s disease, Parkinson’s disease and multiple sclerosis and we provide, for the first time, evidence of senescence in neurons and glia in multiple sclerosis, using the novel GL13 lipofuscin stain as a marker of cellular senescence.

Overview

CoChat Summary

TL;DR

This review argues that cellular senescence contributes to ageing and neurodegenerative disease, with senescent cells accumulating in the nervous system and potentially influencing disease susceptibility, onset, and progression. It also reports novel GL13 lipofuscin evidence of senescent glia and neurons in secondary progressive multiple sclerosis lesions.

Key findings

  • Cellular senescence is a homeostatic response triggered by irreparable DNA damage; senescent cells increase with ageing and are implicated in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The review states a primary causative role in neurodegeneration is unlikely, but senescence may contribute to susceptibility, age at presentation, and rate of progression.
  • Senescence-like features are reported across CNS cell types, including astrocytes, microglia, oligodendrocytes, oligodendrocyte progenitor cells, neurons, and neural stem cells. In aged mice, about 20–80% of mature neurons exhibit a senescence-like phenotype; oligodendrocyte progenitor cells constitute approximately 3–10% of glial cells; brain volume loss may amount to up to 0.4% annually.
  • Disease-specific evidence includes elevated p16INK4a mRNA in PD brain, increased SA-β-gal in CSF from PD patients, and elevated SASP-related cytokines in AD and PD. However, a meta-analysis showed no difference in telomere length between PD patients and age-matched controls, and AD telomere findings remain inconclusive.
  • Novel MS findings: GL13 lipofuscin histochemistry detected lipofuscin+ glial cells in acute active and chronic active demyelinated white matter lesions from SP-MS cases, sparse cells in chronic inactive lesions, none in normal appearing white matter, and granular lipofuscin deposits in numerous neurons in subpial demyelinated cortical lesions and normal appearing cortex.

Methods

  • Narrative review of cellular senescence in ageing and neurodegeneration, focusing on Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
  • For the new MS evidence, the authors used GL13 (SenTraGor) lipofuscin histochemistry as a senescence marker on MS white matter lesions, normal appearing white matter, and cortical lesions; they also cite cuprizone-induced demyelination model data with correlation analysis between senescent glial cell number and demyelination/motor performance.
  • No systematic review, meta-analysis, or primary sample size/statistical methods are stated for the MS histochemistry.

Limitations

  • Stated: evidence connecting cellular senescence with mechanisms of neurodegeneration remains indirect and further investigation is required.
  • Stated: the MS findings merit further quantitative investigation to differentiate ageing effects from MS and to associate senescence extent with other pathological and clinical parameters.
  • Stated: no universal specific senescence marker exists and no consensus on optimal marker combination; senescence features are variable and cell-type specific. Evident: as a narrative review, it does not provide systematic search/quality assessment, and the primary MS histochemistry sample details are not reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms19102937

Cites

374 of 374 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Lipofuscin accumulation as a marker of cellular senescence in multiple sclerosis lesions. Demyelinated lesions were identified with myelin basic protein (MBP) immunohistochemistry and were staged according to Trapp et al. (1998) [287] as acute active, chronic active or chronic inactive using human leukocyte antigen-DR isotype (HLA-DR) immunohistochemistry on serial sections from paraffin embedded postmortem tissue blocks. Lipofuscin was detected with the GL13 hybrid histochemistry-immunohistochemistry method [58]. Acute active demyelinated white matter lesion with MBP staining showing ongoing perivascular demyelination in subcortical white matter from the parietal lobe of a 73-year-old secondary progressive multiple sclerosis (SP-MS) patient (MS51) (A(i)). Infiltration with HLA-DR+ cells with macrophage morphology throughout the demyelinated parenchyma (HLA DR immunohistochemistry) (A(ii)). Perivascular infiltration with CD8+ lymphocytes (CD8 immunohistochemistry) (A(iii)). GL13 staining in acute active lesions showed lipofuscin+ cells. Although many of them were perivascularly localized, some were not, suggesting that at least some of them maybe glial cells rather than inflammatory cells (A(iv)). Chronic actively demyelinating perivenentricular white matter lesion with a fully demyelinated lesion center (lack of MBP immunoreactivity) from a 74-year-old female MS patient (MS265) (B(i)). Typically, HLA-DR immunohistochemistry of serial sections exhibited a border infiltrated by numerous macrophages whereas the lesion centre is infiltrated by ramified microglia (B(ii)). Few CD8+ lymphocytes are present perivascularly (CD8 immunohistochemistry) (B(iii)). Lipofuscin+ cells with granular staining were found in the macrophage infiltrated lesion border (B(iv)). Chronic inactive subcortical white matter demyelinated lesion (lack of MBP immunoreactivity with a well demarcated border) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (C(i)). Ramified microglial morphology throughout the demyelinated lesion area and lesion border (HLA-DR immunohistochemistry) typical of a chronic inactive lesion (C(ii)). Decreased axonal density in the demyelinated lesion seen with 200 KDa neurofilament immunohistochemistry (C(iii)). Numerous parenchymal lipofuscin+ cells in the demyelinated white matter. Lack of HLA-DR+ macrophages from the chronic demyelinated lesion suggests that the lipofuscin+ cells are glial (C(iv)). Subpial cortical demyelination (lack of MBP immunoreactivity extending from the pial surface into the deeper cortical layers from the parietal cortex of a 71-year-old female SP-MS patient (MS33) (D(i)). HLA-DR+ ramified microglia in the demyelinated cortical lesion (D(ii)) and few CD8+ lymphocytes infiltrating the adjacent pia matter (D(iii)). Lipofuscin+ cells mostly with neuronal morphology (inset) throughout the demyelinated cortex (D(iv)). Normal appearing cortex with intact appearing cortical myelin (MBP immunohistochemistry) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (E(i)), HLA-DR immunoreactivity revealing quiescent ramified microglia (E(ii)) and normal-appearing axonal staining with 200 kDa neurofilament immunohistochemistry on a serial section (E(iii)). GL13 staining showed numerous lipofuscin+ cells mostly with neuronal morphology (E(iv)). Scale bars represent 500 μm (A(i),A(ii),B(i),B(ii),C(i),C(ii),C(iii),D(i),D(ii),E(i),E(ii)), 50 μm (D(iii),E(iii)) or 25 μm (A(iii),A(iv), B(iii), B(iv), C(iv), D(iv), E(iv)).
Figure 1 Lipofuscin accumulation as a marker of cellular senescence in multiple sclerosis lesions. Demyelinated lesions were identified with myelin basic protein (MBP) immunohistochemistry and were staged according to Trapp et al. (1998) [287] as acute active, chronic active or chronic inactive using human leukocyte antigen-DR isotype (HLA-DR) immunohistochemistry on serial sections from paraffin embedded postmortem tissue blocks. Lipofuscin was detected with the GL13 hybrid histochemistry-immunohistochemistry method [58]. Acute active demyelinated white matter lesion with MBP staining showing ongoing perivascular demyelination in subcortical white matter from the parietal lobe of a 73-year-old secondary progressive multiple sclerosis (SP-MS) patient (MS51) (A(i)). Infiltration with HLA-DR+ cells with macrophage morphology throughout the demyelinated parenchyma (HLA DR immunohistochemistry) (A(ii)). Perivascular infiltration with CD8+ lymphocytes (CD8 immunohistochemistry) (A(iii)). GL13 staining in acute active lesions showed lipofuscin+ cells. Although many of them were perivascularly localized, some were not, suggesting that at least some of them maybe glial cells rather than inflammatory cells (A(iv)). Chronic actively demyelinating perivenentricular white matter lesion with a fully demyelinated lesion center (lack of MBP immunoreactivity) from a 74-year-old female MS patient (MS265) (B(i)). Typically, HLA-DR immunohistochemistry of serial sections exhibited a border infiltrated by numerous macrophages whereas the lesion centre is infiltrated by ramified microglia (B(ii)). Few CD8+ lymphocytes are present perivascularly (CD8 immunohistochemistry) (B(iii)). Lipofuscin+ cells with granular staining were found in the macrophage infiltrated lesion border (B(iv)). Chronic inactive subcortical white matter demyelinated lesion (lack of MBP immunoreactivity with a well demarcated border) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (C(i)). Ramified microglial morphology throughout the demyelinated lesion area and lesion border (HLA-DR immunohistochemistry) typical of a chronic inactive lesion (C(ii)). Decreased axonal density in the demyelinated lesion seen with 200 KDa neurofilament immunohistochemistry (C(iii)). Numerous parenchymal lipofuscin+ cells in the demyelinated white matter. Lack of HLA-DR+ macrophages from the chronic demyelinated lesion suggests that the lipofuscin+ cells are glial (C(iv)). Subpial cortical demyelination (lack of MBP immunoreactivity extending from the pial surface into the deeper cortical layers from the parietal cortex of a 71-year-old female SP-MS patient (MS33) (D(i)). HLA-DR+ ramified microglia in the demyelinated cortical lesion (D(ii)) and few CD8+ lymphocytes infiltrating the adjacent pia matter (D(iii)). Lipofuscin+ cells mostly with neuronal morphology (inset) throughout the demyelinated cortex (D(iv)). Normal appearing cortex with intact appearing cortical myelin (MBP immunohistochemistry) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (E(i)), HLA-DR immunoreactivity revealing quiescent ramified microglia (E(ii)) and normal-appearing axonal staining with 200 kDa neurofilament immunohistochemistry on a serial section (E(iii)). GL13 staining showed numerous lipofuscin+ cells mostly with neuronal morphology (E(iv)). Scale bars represent 500 μm (A(i),A(ii),B(i),B(ii),C(i),C(ii),C(iii),D(i),D(ii),E(i),E(ii)), 50 μm (D(iii),E(iii)) or 25 μm (A(iii),A(iv), B(iii), B(iv), C(iv), D(iv), E(iv)).CC BY · PubMed Central

Verification

Claims the paper makes

34 Valid · 2 Not valid · 116 Not checked · 33 Own results and interpretations

122 more claims · 25 with their cited sources checked

Create a free account to see all 185 claims and to verify the 214 references still open.

See all claims — free account
  • Probably not a substantial claim. 12
  • It may state two separate claims as one. 49

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 374 references

Research works printed but not linked: 2

  1. Ay M. Charli A. Jin H. Anantharam V. Kanthasamy A. Kanthasamy A.G. Quercetin Nutraceuticals Gupta R.C. Academic Press Boston, MA, USA 2016 447 452
  2. Schnekenburger M. Diederich M. Nutritional Epigenetic Regulators in the Field of Cancer: New Avenues for Chemopreventive Approaches Epigenetic Cancer Therapy Gray S.G. Academic Press Boston, MA, USA 2015 393 425

Cited by

Items 101–200 of 442

Metadata

Authors
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D.
Affiliations
  • National and Kapodistrian University of Athens (GR)
  • Laboratory of Histology & Embryology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Goudi, 115-27 Athens, Greece
Corresponding author
  • Gorgoulis, Vassilis G.
  • Papadopoulos, Dimitrios
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-09-27
Volume
19
Issue
10
Pages
2937
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2892390537
Cited by
448
References
385
Citations by year
2026: 46 · 2025: 63 · 2024: 90 · 2023: 63 · 2022: 57 · 2021: 58 · 2020: 47 · 2019: 23 · 2018: 1
FWCI
4.23
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Multiple Sclerosis Society (207495)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
cellular senescence, aging, neurodegenerative diseases, senescence markers, lipofuscin, neurons, glial cells, Alzheimer's disease, Parkinson's disease, multiple sclerosis, senolytics, age-related diseases
MeSH terms
Aging, Animals, Humans, Cellular Senescence, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.